Synopsis
In-silico drug design is a computational strategy that combines a number of tools to help rationalize the various stages of the drug development process. It can assume a critical part in all phases of medication advancement, from preclinical disclosure to late-organize clinical turn of events, including bimolecular target identification, lead compound selection or design, compound modification to improve affinities, and pharmacokinetic and pharmacodynamic parameters. Its application in drug development aids in the selection of only a potent lead molecule, preventing late-stage clinical failures and resulting in a significant cost reduction. This book may help the researchers working in field of in-silico drug discovery for planning their work and execute that effectively.
Les informations fournies dans la section « Synopsis » peuvent faire référence à une autre édition de ce titre.
Résultats de recherche pour In-Silico Approach for Alpha-Glycosidase and Urease...
Image fournie par le vendeur
In-Silico Approach for Alpha-Glycosidase and Urease Inhibitor Search
Edité par
LAP LAMBERT Academic Publishing Okt 2021, 2021
ISBN 10 : 620420985X
ISBN 13 : 9786204209852
Neuf
Taschenbuch
Vendeur : BuchWeltWeit Ludwig Meier e.K., Bergisch Gladbach, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - it takes 3-4 days longer - Neuware -In-silico drug design is a computational strategy that combines a number of tools to help rationalize the various stages of the drug development process. It can assume a critical part in all phases of medication advancement, from preclinical disclosure to late-organize clinical turn of events, including bimolecular target identification, lead compound selection or design, compound modification to improve affinities, and pharmacokinetic and pharmacodynamic parameters. Its application in drug development aids in the selection of only a potent lead molecule, preventing late-stage clinical failures and resulting in a significant cost reduction. This book may help the researchers working in field of in-silico drug discovery for planning their work and execute that effectively. 168 pp. Englisch. N° de réf. du vendeur 9786204209852
Acheter neuf
EUR 71,90
Expédition à EUR 23
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 2 disponible(s)
Image fournie par le vendeur
In-Silico Approach for Alpha-Glycosidase and Urease Inhibitor Search
Edité par
LAP LAMBERT Academic Publishing, 2021
ISBN 10 : 620420985X
ISBN 13 : 9786204209852
Neuf
Couverture souple
Vendeur : moluna, Greven, Allemagne
Évaluation du vendeur 4 sur 5 étoiles
Etat : New. N° de réf. du vendeur 526153380
Acheter neuf
EUR 58,12
Expédition à EUR 48,99
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : Plus de 20 disponibles
Image fournie par le vendeur
In-Silico Approach for Alpha-Glycosidase and Urease Inhibitor Search
Edité par
LAP LAMBERT Academic Publishing Okt 2021, 2021
ISBN 10 : 620420985X
ISBN 13 : 9786204209852
Neuf
Taschenbuch
Vendeur : buchversandmimpf2000, Emtmannsberg, BAYE, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. This item is printed on demand - Print on Demand Titel. Neuware -In-silico drug design is a computational strategy that combines a number of tools to help rationalize the various stages of the drug development process. It can assume a critical part in all phases of medication advancement, from preclinical disclosure to late-organize clinical turn of events, including bimolecular target identification, lead compound selection or design, compound modification to improve affinities, and pharmacokinetic and pharmacodynamic parameters. Its application in drug development aids in the selection of only a potent lead molecule, preventing late-stage clinical failures and resulting in a significant cost reduction. This book may help the researchers working in field of in-silico drug discovery for planning their work and execute that effectively.VDM Verlag, Dudweiler Landstraße 99, 66123 Saarbrücken 168 pp. Englisch. N° de réf. du vendeur 9786204209852
Acheter neuf
EUR 71,90
Expédition à EUR 60
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)
Image fournie par le vendeur
In-Silico Approach for Alpha-Glycosidase and Urease Inhibitor Search
Edité par
LAP LAMBERT Academic Publishing, 2021
ISBN 10 : 620420985X
ISBN 13 : 9786204209852
Neuf
Taschenbuch
Vendeur : AHA-BUCH GmbH, Einbeck, Allemagne
Évaluation du vendeur 5 sur 5 étoiles
Taschenbuch. Etat : Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - In-silico drug design is a computational strategy that combines a number of tools to help rationalize the various stages of the drug development process. It can assume a critical part in all phases of medication advancement, from preclinical disclosure to late-organize clinical turn of events, including bimolecular target identification, lead compound selection or design, compound modification to improve affinities, and pharmacokinetic and pharmacodynamic parameters. Its application in drug development aids in the selection of only a potent lead molecule, preventing late-stage clinical failures and resulting in a significant cost reduction. This book may help the researchers working in field of in-silico drug discovery for planning their work and execute that effectively. N° de réf. du vendeur 9786204209852
Acheter neuf
EUR 72,76
Expédition à EUR 61,34
Expédition depuis Allemagne vers Etats-Unis
Expédition depuis Allemagne vers Etats-Unis
Quantité disponible : 1 disponible(s)